Cosmos HealthCOSM -7.07%29 EPS without NRI is $-0.67 as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 102 Medical Distribution companies, Cosmos Health ranks better than 93.14% on this metric.
Cosmos Health's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $-0.05.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.67.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 72.60% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -2.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Cosmos Health's EPS without NRI or its related term are showing as below:
COSM'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -254.3 Med: -15.1 Max: 82.3
Current: 72.6
During the past 13 years, Cosmos Health's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 82.30% per year. The lowest was -254.30% per year. And the median was -15.10% per year.
COSM's 3-Year EPS without NRI Growth Rate is ranked better than 93.14% of 102
companies
in the Medical Distribution industry
Industry Median: 2.45
vs COSM: 72.60
Cosmos Health's EPS (Diluted) for the
three
months ended in Mar. 2026 was $-0.06.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.64.
Cosmos Health's EPS (Basic) for the
three
months ended in Mar. 2026 was $-0.06.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.64.
Cosmos Health (NAS:COSM) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Cosmos Health EPS without NRI Related Terms
Cosmos Health EPS without NRI Historical Data
* Premium members only.
The historical data trend for Cosmos Health's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSM vs HKPD, VNOV, SNYR: EPS without NRI Comparison
For the Medical Distribution subindustry, Cosmos Health's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health PE Ratio without NRI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Cosmos Health's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a EPS without NRI of $-0.67 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #7 out of 102 companies in the Medical Distribution industry, placing it in the top 6.9%.
Is Cosmos Health's EPS without NRI too high?
Cosmos Health's current EPS without NRI is $-0.67. Based on the distribution chart, Cosmos Health ranks #7 out of 102 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's EPS without NRI compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #7 out of 102 companies for EPS without NRI. This places Cosmos Health in the top 7% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.45, based on 102 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current EPS without NRI is $-0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.17 — trading 52.2% below its estimated fair value. The current EPS without NRI is $-0.67. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Cosmos Health (COSM), the current EPS without NRI is $-0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.17 is trading 52.2% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
EPS without NRI: $-0.67
GF Value™: $0.36 vs. price of $0.17 (52.2% below fair value)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
